ATXS
Astria Therapeutics Inc.
$6.18
-$0.35(-5.36%)
70
Overall
--
Value
70
Tech
--
Quality
Market Cap
$376.42M
Volume
235.51K
52W Range
$3.56 - $12.92
Target Price
$29.33
EPS Estimates Overview
| Current Quarter | $-0.42 | Next Quarter | $-0.55 |
| Current Year | $-2.09 | Next Year | $-2.25 |
| QoQ Growth | -31.0% | YoY Growth | -7.7% |
| 3Y EPS CAGR | N/A | Target Price | $29.33 |
| Consensus | Buy | Upside | +374.6% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ATXS | $6.18 | -5.4% | 235.51K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Astria Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW